Pursuant to Regulation 39(3) of SEBI (Listing obligation and Disclosure Requirement) Regulation, 2015 (Listing Regulations) Ajanta Pharma has informed that the company has on 15th December 2021 issued duplicate share certificate of the shareholder, Chandulal Agrawal (Folio No: 0000285). Further details are attached.
The above information is a part of company’s filings submitted to BSE.